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Mutations in the Cone-Rod Homeobox Gene
Are Associated with the Cone-Rod
Dystrophy Photoreceptor Degeneration
gene expression. In the retina, an increasing number
of the transcription factors that regulate tissue-specific
gene expression are being identified (Swaroop et al.,
1992; Freund et al., 1996). Genetic analysis of these
factors is beginning to shed light on their function in
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1Department of Ophthalmology mouse of the paired class homeodomain gene Chx10
2Department of Human Genetics suggests that it is involved in the proliferation of neuro-
3Department of Neuroscience retinal precursors and is necessary for the generation
4Department of Bioengineering of differentiated bipolar cells (Burmeister et al., 1996).
W. K. Kellogg Eye Center Similarly, knock out of the POU homeodomain gene
University of Michigan Brn-3b indicates that it plays an important role in the
Ann Arbor, Michigan 48105 development of some subclasses of retinal ganglion
5Department of Ophthalmology cells (Erkman et al., 1996; Gan et al., 1996). Knock out
6Department of Molecular Biology and Genetics of the Rx homeodomain gene, which results in a failure
Department of Neuroscience of eye formation, demonstrates that Rx is a key molecule
Johns Hopkins University School of Medicine in the early stages of eye development (Mathers et al.,
Baltimore, Maryland 21287 1997).
7Department of Ophthalmology Using a yeast one-hybrid screen with ªbaitsº from the
University of Iowa Medical School promoter region of the gene for the rod visual pigment
Iowa City, Iowa 52242 rhodopsin (Kumar et al., 1996), we recently identified a
8Midtown Medical Center novel paired-like homeodomain protein, Cone-Rod Ho-
Denver, Colorado 80205 meobox (Crx), which has characteristics suggesting that
9University of Illinois Eye and Ear Infirmary it may play a significant role in the regulation of photore-
Chicago, Illinois 60612 ceptor gene expression (Chen et al., 1997). Crx belongs
10Department of Ophthalmology to the otd/Otx family, members of which are important
Scheie Eye Institute in the development of anterior head structures and in
University of Pennsylvania cell lineage determination (Finkelstein and Boncinelli,
Philadelphia, Pennsylvania 19104 1994). Crx appears to be one of the earliest known mark-
ers of photoreceptor identity. Its expression begins as
early as embryonic day 12.5 in the mouse, which is
Summary the time of cone cellular determination, and increases
dramatically at postnatal day 3, which is near the time
Crx is a novel paired-like homeodomain protein that of maximal rod genesis (Carter and LaVail, 1979). In the
is expressed predominantly in retinal photoreceptors adult, it is expressed predominantly in cone and rod
and pinealocytes. Its gene has been mapped to chromo- cells. In vitro studies with the recombinant Crx protein
some 19q13.3, thesite of adisease locus for autosomal have demonstrated that it binds specifically to the Ret
dominant cone-rod dystrophy (CORDII). Analysis of 1, BAT-1, and Ret 4 sites in the rhodopsin proximal
the proband from a family with autosomal dominant promoter region, elements that were previously impli-
CORD revealed an Arg41Trp substitution in the third cated as being important in regulation of rhodopsin gene
residue of the CRX homeodomain. The sequence expression (Morabito et al., 1991; Yu and Barnstable,
change cosegregated with the disease phenotype and 1994; Chen and Zack, 1996; DesJardin and Hauswirth,
was not detected in 247 normal controls. Recombinant 1996; Yu et al., 1996). Crx transactivates the expression
CRX homeodomain containing the Arg41Trp substitu- of rhodopsin and a number of other photoreceptor-
tion showed decreased DNA binding activity. Analysis specific genes in cultured cells. It acts synergistically
of another 169 CORD probands identified three addi- with the bZIP transcription factor neural retina leucine
tional CRX sequence variations (Arg41Gln, Val242Met,
zipper (NRL) (Swaroop et al., 1992), which demonstrates
and a 4 bp deletion in codons 196/7) that were not found
an overlapping pattern of expression with Crx duringamong thecontrols. This datasuggests that mutations
retinal development (Liu et al., 1996), and has itself beenin the CRX gene are associated with photoreceptor
implicated in rhodopsin regulation (Kumar et al., 1996;degeneration and that the Crx protein is necessary for
Rehemtulla et al., 1996).the maintenance of normal cone and rod function.
To examine the role of Crx in vivo, we undertook a
genetic approach. We cloned the human CRX gene
and determined that it mapped to chromosome 19q13.3Introduction
(Chen et al., 1997), the site of one of several autosomal
dominant cone-rod dystrophy loci (CORDII) (Evans etDifferentiation and maintenance of neuronal functions
al., 1994; Gregory et al., 1994). The CORDs are a clini-requires appropriate regulation of complex patterns of
cally and genetically heterogeneous group of diseases
that exhibit early loss of central visual acuity and color11 To whom correspondence should be addressed.
12 These authors contributed equally to this work. vision, with progressive loss of peripheral vision. This
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Figure 1. Genomic Structure of the Human
CRX Gene
(A) Schematic diagram showing the relative
size and position of the three exons that
contain the CRX coding region. Note that
there is an additional exon upstream of exon
1 that contains only 59-untranslated region
sequence, but its exact borders have not
been defined. It is not shown in the figure.
(B) Intron±exon border sequences and flank-
ing 59- and 39-untranslated region sequences
for the three coding region exons. The C/T
polymorphism in intron 1 is underlined (see
text). 159-untranslated sequence. 239-untrans-
lated sequence.
phenotype is clinically distinct from retinitis pigmentosa, not observed in 247 normal controls (55 individuals were
tested by direct sequencing and restriction digestin which the initial pathology is largely in the midperiphe-
ral retina rather than in the macula, and the loss of rod and 192 by single-strand conformational polymorphism
[SSCP] analysis; data not shown). In addition, it shouldphotoreceptor function precedes that of cones. In their
end stages, however, these diseases are often difficult be noted that all otd/Otx-like proteins contain an argi-
nine at the third residue of the homeodomain, and theto distinguish. The clinical phenotype associated with
CORDII generally involves an early onset macular lesion only homeodomains containing a tryptophan at this lo-
cation are an atypical subgroup consisting of the H2.0,and a severe clinical course, usually resulting in blind-
ness before the age of 50 (Evans et al., 1995). Unlike Hlx, HB24, and Hal-hlx proteins (Duboule, 1994).
some other forms, CORDII is not knownto be associated
with systemic or other manifestations. Recombinant Homeodomain Containing the
Arg41Trp Substitution DemonstratesHere, we report the identification of a putative dis-
ease-causing mutation (Arg41Trp) in the homeodomain Decreased DNA Binding Activity
To examine the possible functional consequences of theof the CRX protein in a CORD pedigree with an appar-
ently autosomaldominant mode of inheritance and dem- Arg41Trp substitution, we compared the DNA binding
activity of recombinant wild-type CRX homeodomain±onstrate that the substitution causes a decrease in DNA
binding activity. Analysis of additional probands re- glutathione S-transferase fusion protein (CrxHD±GST)
with equivalent protein containing the Arg41Trp substi-vealed three other sequence changes in the CRX gene
that may also be associated with the disease phenotype. tution (CrxHDArg41Trp±GST) (Figure 3A). We had previously
demonstrated that CrxHD±GST binds to the Ret 1,We present a clinical description of the Arg41Trp family
and discuss the implications of our results for the role BAT-1, and Ret 4 sites in the rhodopsin proximal pro-
moter region (Chen et al., 1997). In an electrophoreticof the CRX protein in the development and maintenance
of normal photoreceptor function. mobility shift assay (EMSA), CrxHDArg41Trp±GST demon-
strated significantly reduced binding to the Ret 1 and
BAT-1 sites (Figures 3B and 3C). Its binding to the RetResults
4 site was barely detectable (Figure 3D). These findings
are consistent with the Arg41Trp substitution being aArg41Trp Substitution Cosegregates with Disease
in a CORD Family functionally important mutation.
As a first step for mutation analysis, the human CRX
gene was isolated and its genomic organization deter- Clinical Characterization of Arg41Trp
CORD Familymined (Figure 1A). The 897 bp CRX coding region is
contained in three exons, with the homeodomain split The core clinical features in pedigree #H0992 are normal
vision during childhood and young adult years, with de-between exons 1 and 2. The intron±exon boundaries
are consistent with known splice consensus sequences velopment of progressive vision loss centrally beginning
at 35±50 years of age. The deceased father (II-2, Figure(Mount, 1982) (Figure 1B).
Since we did not have available any CORD families 2B) had been diagnosed in 1957 with 20/200 acuities
from ªpresenile macular degenerationº that began inin which the disease locus had been mapped to19q13.3,
we screened a cohort of 170 probands from families his mid-30's. He reported that his father (I-1) and two
brothers were also affected, consistent with autosomalwith the diagnosis of CORD for CRX mutations. The
sequence analysis revealed a proband with a single nu- dominant inheritance. The three affected siblings (III-1,
III-7, and III-9) reported first noticing vision problemscleotide change in codon 41 (CGG to TGG) in one allele,
resulting in an Arg41Trp substitution in the third residue between 37 and 45 years of age. All three had early and
patchy atrophy of the retinal pigment epithelium (RPE)of the homeodomain (Figure 2A). The extended pedigree
of this family (#H0992) is shown in Figure 2B. The codon in the macula and beneath the arcade vessels at 208±408
peripherally in the region of highest rod density (Figures41 sequence change cosegregated with the disease in
the pedigree through eight meioses (Figure 2C), pro- 4A and 4B). Visual field testing revealed relative blind
spot regions (scotomas) within the area of central visionviding a lod score of 2.1 (data not shown), and was
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age 45, but by age 52, his acuities were still 20/20 for
both eyes. His macula showed punctate pigmentary ab-
normality of the RPE and early mild atrophy that ex-
tended into the nasal retina. His ERG was the least
affected of the three, with normal b-wave amplitudes
for scotopic rod and photopic cone conditions (Figure
4C). However, his ERG showed abnormalities: his cone
30 Hz flicker implicit time (from flash to response peak)
was marginally prolonged to 31 ms, and the white sco-
topic responses to the bright flash were ªelectronega-
tiveº (Figure 4C, arrow). These changes suggested dif-
fuse rod and cone disease. III-1 was tested again 5 years
later at age 57, and progression was noted: acuities had
dropped slightly to 20/30 in both eyes, his central blind
spots were not larger but were more dense (now to
the V4e target), and his photopic cone response had
become electronegative like III-9, even though the 30
Hz flicker implicit time and amplitude had not changed
(data not shown).
Other CRX Mutations May Also Be
Associated with CORD
The screening of the CORD cohorts identified four addi-
tional probands with sequence changes in one of their
CRX alleles (Figure 5). One of them also showed a nucle-
otide change in the Arg41 codon, but in this proband,
a G-to-A transition resulted in an arginine-to-glutamine
substitution. Among a compilation of 346 homeodomain
sequences (Duboule, 1994), none had a glutamine resi-
due at this position. Unfortunately, no other members
from the Arg41Gln family, nor from the families below,
were available for clinical or DNA testing.
The three other changes that were identified were a
GCC-to-ACC change in codon 158, resulting in an Ala-
to-Thr substitution; a 4 bp deletion involving codons
196 and 197, resulting in a frame shift and premature
Figure 2. Arg41Trp Substitution Cosegregates with the CORD Phe- termination; and a GTG-to-ATG change in codon 242,
notype in Pedigree #H0922 resulting in a Val-to-Met substitution (Figure 5). All of
(A) Sequence analysis of CRX exon 2. The sequence of the antisense the patients with these sequence changes had clinical
strand in the region of the C-to-T transition is shown. The A numbers and electrophysiological findings consistent with CORD.
on top indicate the proband number. The nucleotide substitution is
The Arg41Gln, Val242Met, and 196/197 deletion alleles,detected in patient A1117 and is indicated by an arrow.
using the same SSCP protocol that was used to identify(B) Pedigree #H0992 through three generations. Solid squares and
them, were not found in a group of 192 normal controls.circles indicate affected males and females, respectively.
(C) Segregation of Arg41Trp mutation in the pedigree. Since the The Ala158Thr substitution, however, was observed in
transition from C to T resulted in the loss of restriction site for FauI 2/110 control chromosomes. The only other sequence
(CCCGC(N)4/GGGCG(N)6; produced by SibEnzyme, Novosibirsk, variation detected was a common polymorphism, a
Russia, and obtained from New England Biolabs), the amplified C-to-T substitution at the 112 position in intron 1 (see
products of CRX exon 2 were digested with FauI and analyzed
Figure 1), which was present in approximately 25% ofon a 2% agarose gel. Solid squares and circles indicate affected
both normal and patient chromosomes.males and females, respectively. The gray square represents the
deceased father, who was legally blind during the later part of his
life and presumably carried the mutation. The affected individuals
Discussioncarry both a normal and a mutated allele. L shows 100 bp ladder
of DNA markers.
Previous studies implicated Crx as a potentially impor-
tant regulator of photoreceptor gene expression both
during development and in the adult retina (Chen et al.,(Figure 4C). Color vision was abnormal (Table 1). Rod
psychophysical threshold was elevated by 0.5 log units 1997). However, since this data was mostly in vitro in
nature, it did not directly address the role of Crx inat some points in the macula, but rod thresholds were
normal at multiple peripheral points for all three. Wide- vivo. In this report, we describe the identification of five
potentially mutant alleles of the human CRX gene thatspread cone disease was indicated by delayed photopic
flicker implicit timing on full-field electroretinogram are associated with CORD, thereby providing strong
evidence that the CRX protein is indeed required for the(ERG) testing (Figure 4C, triple arrows).
Patient III-1 had sought help for vision problems at maintenance of normal rod and cone function in vivo.
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Figure 3. Arg41Trp Substitution Is Associ-
ated with Decreased DNA Binding Activity
(A) Protein gel demonstrating purification of
CrxHD±GST and CrxHDArg41Trp±GST fusion
peptides. Lane 1 contains protein molecular
weight markers (BRL); lanes 2 and 3 each
contain 100 ng of the indicated protein; the
numbers adjacent to the markers represent
the apparent molecular weights (kilodaltons).
(B±D) EMSAs with CrxHD±GST (lanes 1±3)
and CrxHDArg41Trp±GST (lanes 4±6) fusion pep-
tides. The 32P-labeled probes used are indi-
cated on the bottom of each figure. The
amount of fusion protein used for lanes 1 and
4, 2 and 5, and 3 and 6 were 10, 2, and 0.4
ng, respectively, for (B); 2, 0.2, and 0.02 ng,
respectively, for (C); and 60, 40, and 20 ng,
respectively, for (D).
Several lines of evidence suggest that at least some eight meioses. (3) The Arg41Trp mutation causes a
charge and hydrophobicity change at a conserved andof the identified CRX sequence changes are mutations
that are causally related to the CORD phenotype: (1) potentially important site, the third residue of the ho-
meodomain. The Crx homeodomains are completelyseveral families with CORD have been mapped to
19q13.3 (Evans et al., 1994; Gregory et al., 1994), the conservedbetween mouse, cow, and man. Furthermore,
the arginine residue itself isconserved between all mem-site of the CRX gene. The fraction of CORD cases that
are linked to 19q13.3, however, is unknown. (2) In bers of the otd/Otx family, and in a compilation of 346
homeodomains, a basic amino acid (Arg or Lys) is pres-pedigree #H0992, there is perfect cosegregation of the
Arg41Trp allele with the clinical phenotype through ent in 312 of the proteins (Duboule, 1994). Based on
Figure 4. Clinical Characterization of Pa-
tients from Pedigree #H0992
(A) Fundus photograph of the right eye of III-9,
a 39-year-old male, shows a crescent of peri-
foveal RPE atrophy from 3- to 7-o'clock posi-
tion and extensive RPE atrophy underneath
the macular arcade vessels (right and bottom
of photograph). The arterioles are narrowed.
(B) Fluorescein angiogram of macula of the
right eye of III-9 shows extensive RPE atrophy
along the macular arcade vessels (right and
bottom of photograph) causing a ªwindow
defectº through which the bright choroidal
fluorescence is evident. This is the rod-dense
region of the retina between 208±408 from the
fovea.
(C) Retinal function testing on three affected
siblings. ERG responses to scotopic bright
white flashes (10 cd-s/m2, dark-adapted con-
dition) are primarily from rods and rod path-
way neurons; arrow highlights ªelectronega-
tiveº shape form loss of positive-going
b-wave that did not even return to baseline.
Blue scotopic flash (0.014 cd-s/m2) elicits the
rod system signature maximal b-wave that
is normal for III-1 but abnormal for III-7, -9.
Photopic flash (10 cd-s/m2 flash on 43 cd/m2
light-adapting background) and 30 Hz flicker
elicit responses primarily from cone pathway
neurons; single arrow highlights b-wave loss,
and triple arrows indicate delayed flicker im-
plicit timing. Visual fields show central rela-
tive blind spots of >308 tested with the Gold-
mann perimeter I4e target but with retention
of full peripheral fields to both target sizes.
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the crystal structure of engrailed, homeodomain Arg-3
(equivalent to Arg-41 in the CRX protein), which is part
of theN-terminal arm,makes contact with theDNA minor
groove (Kissinger et al., 1990). In Drosophila melanogas-
ter paired, which is probably more relevant to CRX due
to its greater similarity in primary sequence, the crystal
structure suggests that Arg-3 is involved in homeodo-
main dimerization, interacting intermolecularly with the
beginning of helix II (Wilson et al., 1995). In addition, the
Arg-3 residue (equivalent to CRX Arg-41) also forms
a charged hydrogen bond with homeodomain Glu-42
(equivalent to CRX Glu-80) (see Figure 5), which itself is
100% conserved among paired class homeodomains.
(4) As predicted based on the paired crystal structure,
the recombinant CRX homeodomain containing the
Arg41Trp substitution demonstrates decreased binding
activity for the rhodopsin promoter (Figure 3). (5) Arg41
is also altered in another family, but in this case to a
glutamine, which as with the tryptophan substitution
represents a change in net charge. (6) The codon 196/7
deletion causes loss of the CRX tail, a potentially impor-
tant region that is conserved among Otx proteins (Chen
et al., 1997). (7) Four of the CORD-associated sequence
changes were not identified among normal control chro-
mosomes. It should also be noted that the temporal and
spatial expression of the Crx gene during mouse retinal
development and its biochemical properties (Chen et al.,
1997) are consistent with the hypothesis that mutation in
the human CRX gene could cause both cone and rod
degeneration in affected patients. Taken together, the
data indicates that the Arg41Trp CRX substitution and
possibly several of the other sequence changes are
likely to be disease-causing mutations.
In the terminology used clinically, the earliest pheno-
type in the Arg41Trp family can be described as a macu-
lar degeneration involving both cones and rods that
evolves into a ªcone-rod dystrophy.º The three affected
siblings had symptoms primarily from central vision loss
due to rod and cone disease in the macula. The reduced
acuity and color vision implicate a cone disease, while
the considerable RPE changes between 208±408 periph-
erally in the region of greatest rod density implicate rod
involvement. The ERG of both III-7 and III-9 showed
widespread cone and rod involvement on initial exami-
nation, and progression was documented in III-1 over
a 5 year interval. Although several of the abnormal ERG
components originate primarily from neural activity
postsynaptic to the photoreceptors (Bush and Sieving,
1994, 1996), it is reasonable to presume that rod and
cone disease accounts for these ERG changes, includ-
ing the 30 Hz flicker delay. The electronegative scotopic
and photopic responses suggest defective signaling by
the depolarizing bipolar cells of the ON visual pathway
(Sieving, 1993), but one cannot know whether this re-
sults from pathology of the bipolar cells or from deficient
photoreceptor signaling. It is, however, surprising that
all three siblings demonstrated normal psychophysical
dark-adapted sensitivities in the periphery, as this indi-
cates normal photon catch by the peripheral rod photo-
receptors and implies that they are in normal or near
normal numbers. It also suggests that their outer seg-
ments are of normal length and that they have normal
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Figure 5. Schematic Diagram Showing the
Location of the Predicted Sequence Changes
Identified in the CRX Gene
The positions of the homeodomain (HD) and
other conserved sequences in the protein,
representing potentially important regions,
are indicated. The Ala158Thr substitution is
shown in brackets because it has also been
identified in two normal controls. The pre-
dicted charged hydrogen bond between
Arg-41 and Glu-80 is also shown, since it
would be interrupted by theresidue 41substi-
tutions.
Experimental ProceduresG-protein±coupled membrane channels. Overall, the
clinical phenotype of this family appears to be less se-
Determination of CRX Genomic Structurevere than that reported for the original CORDII family
A set of human genomic GSI P1 high density filters (Genome Sys-
(Evans et al., 1995). tems) was screened by hybridization with a human CRX cDNA probe,
The molecular mechanism(s) by which CRX mutations and resulting positive clones were ordered and prepared according
to the supplier's directions. Dideoxy cycle DNA sequencing (Ther-cause a dominant phenotype in pedigree #H0992 and
moSequenase, Amersham Life Science) was performed directly onperhaps in the other families is not clear. Possible expla-
the P1 DNA templates using primers corresponding to the humannations include a dominant negative effect as well as
cDNA sequence to determine the intron±exon borders. Approxi-haploinsufficiency, since both over- and underexpres-
mately 3 mg of template was used per reaction, according to the
sion of rhodopsin, one of the targets of CRX activation, supplier's protocol. Sequencing and PCR were used to determine
can cause photoreceptor degeneration (Olsson et al., the length of introns.
1992; Humphries et al., 1997). For example, since the
Expression of Crx Homeodomain and EMSAsArg41Trp mutation causes decreased DNA binding ac-
Recombinant CrxHD±GST and CrxHDArg41Trp±GST were expressed,tivity, unbound mutant molecules could repress tran-
purified, and tested by EMSA as previously described (Chen etscription by squelching (Ptashne, 1988). Alternatively, a
al., 1997). Plasmid CrxHDArg41Trp±GST was generated the same asmutation in the homeodomain could change binding previously described for plasmid CrxHD±GST except that the 59
specificity and lead to aberrant CRX binding, or a muta- oligomer used (ACGGATCCAGCGCCCCCAGGAAGCAGCGGTGGG
tion in the activation domain could create a competitive AGCGCACC) encoded the Arg41Trp substitution.
inhibitor that binds to the appropriate DNA site but no
Clinical Analysislonger activates transcription. Since the CRX and NRL
Pedigree #H0992 was identified and studied at the University ofproteins together transactivate rhodopsin regulation
Michigan (by P. A. S.). Clinical evaluation and retinal function testing,(Chen et al., 1997), it is also possible that some of the
including ERG recordings, visual fields testing, dark-adapted abso-
CRX alleles alter the interaction of mutant protein with lute threshold sensitivity by Goldmann-Weekers determination, and
NRL and thereby lower the rate of transcription of the color vision testing, were performed in standard fashion as pre-
rhodopsin gene. Although mutations in the NRL gene viously described (Sieving, 1993).
have not yet been detected (Farjo et al., 1997), it remains
Mutation Analysisa candidate for various retinal degenerations including
Individuals were tested for sequence variations in the CRX genethe CORDs. It is tempting to speculate that certain al-
either by direct sequencing (method one) or by SSCP analysisleles of CRX and NRL may also modify the clinical phe-
(method two). Informed consent was obtained from participants in
notype observed in patients with retinal dystrophies the study. DNA was prepared from the blood lymphocytes using
caused by mutations in rhodopsin or other photorecep- standard procedures.
For method one, exons and the flanking intronic sequences weretor-specific genes. As one possibility, alterations in tran-
amplified from genomic DNA by PCR using primer pairs (see below)scription factors that reduce the level of expression of
derived from the CRX sequence (Chen et al., 1997). The productsphotoreceptor molecules that cause autosomal domi-
were directly sequenced without purification, using the Sequenasenant retinal disease could lead to a less severe pheno-
kit with 33P-labeled terminators (Amersham Life Science), as de-
type (Olsson et al., 1992) and thereby provide a new scribed (Fujita et al., 1997).
avenue for therapeutic intervention. For method two, SSCP was performed essentially as described
(Stone et al., 1997). Following electrophoresis, gels were silverSeveral studies have shown that mutations in a single
stained as previously described (Bassam et al., 1991). PCR productsgene can lead to a wide variety of different clinical phe-
were sequenced using fluorescent dideoxynucleotides on an Ap-notypes. For example, mutations in the RDS/peripherin
plied Biosystems (ABI) model 373 automated sequencer. All muta-gene result in RP, CORD, or macular degeneration (Keen
tions were recognized by the approximately equal peak intensity of
et al., 1994; Wroblewski et al., 1994; Nakazawa et al., two fluorescent dyes at the mutant base.
1996; Fishman et al., 1997). It, therefore, seems reason- The primer pairs used were as follows: method one: exon 1, 59CCT
CAGTGTCCCCGAAGA39/59TGCCAAGAGAAACGACTGTACT39; exonable to hypothesize that mutations in the CRX gene
2, 59GGTCCTGTTTCCCATCCC39/59ACCCACCACCCCACCTGAAC39;might also be associated with retinal diseases other
exon 3A, 59TTCCCCACTTACCCACCC39/59GGACTGTAGGAATCTGthan CORD. Future genetic analyses of other patient
AGATGCC 39; exon 3B, 59TCCCCAAGACCCTCCACAG39/59AGCpopulations, as well as mouse knock-out and transgenic
TCGGAGACCCATAGGC39; exon 3C, 59CCTCCGCTTTCTGCTCTT
studies, will hopefully provide additional insights into C39/59CCCGATGGAGAGAGATGGAG39.
CRX's role in vivo, as well as broader understanding of Method two: exon 1, 59GTGTCCCCGAAGATCATGATGGCG39/59
CAGAGGTCCTCCAAGAGATGAGGCC39; exon 2, 59GGATGGAATCits role in causing human retinal disease.
CRX Mutations Associated with CORD
1335
TTGGTCATCCCAC39/59CTCTTTGTTCCGGGCAGGCCTC39; exon 3A, chromosome 19q and evidence for segregation distortion. Nat.
Genet. 6, 210±213.59CCTCTTCCCCACTTACCCA39/59CACATCTGTGGAGGGTCTTGG39;
exon 3B, 59CAAGGCCCGGCCTGCCAAG39/59GGCGTAGGTCATGG Evans, K., Duvall, Y.J., Fitzke, F.W., Arden, G.B., Bhattacharya, S.S.,
CATAGG39; exon 3C, 59AGGGCCGTCTCTGACCTCC39/59ATAGCTC and Bird, A.C. (1995). Chromosome 19q cone-rod retinal dystrophy.
TGGCCTGATAGGGA39; exon 3D, 59TCCTATTTCAGCGGCCTAG Ocular phenotype. Arch. Ophthalmol. 113, 195±201.
A39/59GAATTCCAAGCTATCCACGG39; exon 3E, 59TCCCTATCAGG Farjo, Q., Jackson, A., Pieke-Dahl, S., Scott, K., Kimberling, W.J.,
CCAGAGCTAT39/59AGAGAGATGGAGACTGCGTCC39. Sieving, P.A., Richards, J.R., and Swaroop, A. (1997). Human bZIP
Lod score analysis was peformed using M-LINK, part of the LINK- transcription factor gene NRL: structure, genomic sequence, fine
AGE program developed by Dr. Jurg Ott. linkage mapping at 14q11.2 and negative mutation analysis in pa-
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Note Added in Proof
Mutations in CRX associated with CORD were also independently
identified by Freund et al., Cell 91, 543±553 (1997). Interestingly,
one of the two changes they identified was a substitution in Glu-
80, which is the postulated hydrogen-bonding partner of Arg-41
(see Discussion).
